GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novelion Therapeutics Inc (STU:QLTA) » Definitions » Change In Inventory

Novelion Therapeutics (STU:QLTA) Change In Inventory : €-1.0 Mil (TTM As of Mar. 2019)


View and export this data going back to . Start your Free Trial

What is Novelion Therapeutics Change In Inventory?

Novelion Therapeutics's change in inventory for the quarter that ended in Mar. 2019 was €-1.5 Mil. It means Novelion Therapeutics's inventory increased by €1.5 Mil from Dec. 2018 to Mar. 2019 .

Novelion Therapeutics's change in inventory for the fiscal year that ended in Dec. 2018 was €-1.5 Mil. It means Novelion Therapeutics's inventory increased by €1.5 Mil from Dec. 2017 to Dec. 2018 .

Novelion Therapeutics's Total Inventories for the quarter that ended in Mar. 2019 was €11.9 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Novelion Therapeutics's Days Inventory for the quarter that ended in Mar. 2019 was 78.14.

Inventory Turnover measures how fast the company turns over its inventory within a year. Novelion Therapeutics's Inventory Turnover for the quarter that ended in Mar. 2019 was 1.17.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Novelion Therapeutics's Inventory-to-Revenue for the quarter that ended in Mar. 2019 was 0.40.

Novelion Therapeutics Change In Inventory Historical Data

The historical data trend for Novelion Therapeutics's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novelion Therapeutics Change In Inventory Chart

Novelion Therapeutics Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Change In Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 1.97 5.14 -1.49

Novelion Therapeutics Quarterly Data
Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.83 -0.44 0.85 0.07 -1.49

Novelion Therapeutics Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novelion Therapeutics  (STU:QLTA) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Novelion Therapeutics's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=11.534/13.469*365 / 4
=78.14

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Novelion Therapeutics's Inventory Turnover for the quarter that ended in Mar. 2019 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=13.469 / 11.534
=1.17

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Novelion Therapeutics's Inventory to Revenue for the quarter that ended in Mar. 2019 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=11.534 / 28.497
=0.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novelion Therapeutics Change In Inventory Related Terms

Thank you for viewing the detailed overview of Novelion Therapeutics's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Novelion Therapeutics (STU:QLTA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novelion Therapeutics Inc (STU:QLTA) » Definitions » Change In Inventory
Comparable Companies
DFFN TSXV:KLY TSXV:QPT ASX:PTX ROCO:4197 XSAT:WNT PTIX IST:RTALB TROV NOVN MATN LSE:TRX ASX:NYR ATOS TSXV:BCT JAGX TSX:CTX ROCO:6744 ACHV EMBI
Traded in Other Exchanges
N/A
Address
c/o Norton Rose Fulbright, 1800 West Georgia Street, Suite 510, Vancouver, BC, CAN, V6B 0M3
Website
http://www.novelion.com
Headquartered in Vancouver, Canada, QLT is a biotechnology company that researches and develops products used to treat conditions of the eye. After a recent board change, QLT divested its only marketed product, a laser treatment called Visudyne for the treatment of wet age-related macular degeneration and subfoveal choroidal neovascularization. QLT also earns royalty payments on other certain previously divested products. Following recent pipeline changes, the company currently has one product in development for two rare eye conditions.